Unified nanopore platform for simultaneous DNA, RNA, and protein sequencing
Active Definitive Contract Awarded
- Contract number
- 140D0426C0135
- Awardee
-
Electronic Biosciences, Inc. UEI FLHHE89XH2H5
- Awarding agency
-
Interior Business Center
Office of Policy Management and Budget, Department of the Interior
- Obligated
- $2,999,975
Award facts
- Opportunity
-
- PA24245 Solicitation number
- Contract value 100% obligated
- $2,999,975.00 Current and potential, with all options
- Completion date 6% complete
- Current and potential, with all options
- Funding agency
- National Institutes of Health Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92127, USA
- Legislative mandates
-
- Other statutory authority
Award details come from SAM.gov/FPDS.
About this award
The National Institutes of Health awarded a $2.999975 million definitive contract to Electronic Biosciences, Inc. for a unified nanopore platform enabling simultaneous DNA, RNA, and protein sequencing on September 9, 2026, under a total small business set-aside.
The contract carries a firm fixed price structure with an ultimate completion date of September 14, 2028. Place of performance is San Diego, CA 92127.
Electronic Biosciences is a biotechnology company based in San Diego that develops nanopore-based sequencing and diagnostic platforms. The company's technical foundation spans single-molecule sequencing technologies, protein sequencing systems, RNA modification detection, enzyme-based protein sequencing, extracellular vesicle characterization, and point-of-care diagnostic assays. Prior work includes protein sequencing development funded through the National Cancer Institute, RNA modification detection platforms under a National Human Genome Research Institute Phase I SBIR award, and clinical diagnostics including prostate-specific antigen and immunosuppressant drug monitoring assays.
Quick answers
Who was awarded contract 140D0426C0135?
140D0426C0135 was awarded to Electronic Biosciences, Inc. by Interior Business Center (Office of Policy Management and Budget) on September 9, 2026.
How much is contract 140D0426C0135 worth?
The government has obligated $2,999,975 on 140D0426C0135.
Which agency awarded contract 140D0426C0135?
Interior Business Center (Office of Policy Management and Budget) awarded 140D0426C0135, with funding from National Institutes of Health (Department of Health and Human Services).
Was contract 140D0426C0135 competed?
The extent of competition for 140D0426C0135 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award